View ValuationGMR Solutions 将来の成長Future 基準チェック /46GMR Solutions利益と収益がそれぞれ年間79.9%と5.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に36.5% 99.4%なると予測されています。主要情報79.9%収益成長率99.41%EPS成長率Healthcare 収益成長17.7%収益成長率5.5%将来の株主資本利益率36.54%アナリストカバレッジGood最終更新日18 Aug 2026今後の成長に関する最新情報お知らせ • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.お知らせ • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.すべての更新を表示Recent updatesお知らせ • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ellen Zane was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jul 24GMR Solutions Inc. to Report Q2, 2026 Results on Aug 13, 2026GMR Solutions Inc. announced that they will report Q2, 2026 results Pre-Market on Aug 13, 2026お知らせ • Jul 11GMR Solutions Inc.Appoints Jan Stern Reed to Chair of the Board's Nominating, Corporate Governance and Compliance Committee and A Member of the Board's Audit CommitteeGMR Solutions Inc. As of July 1, 2026, Ms. Jan Stern Reed 's preliminary committee assignments have been finalized. Ms. Reed is serving as the Chair of the Board's Nominating, Corporate Governance and Compliance Committee and a member of the Board's Audit Committee.ナラティブ更新 • Jul 10GMRS: Higher Discount Rate Will Pressure Confidence In Air Operations DeliveryThe analyst price target for GMR Solutions has been reduced from $15 to $14, as analysts factor in a higher discount rate while still highlighting the company’s scale in U.S. emergency medical services and the potential benefits from higher margin air operations and contract stability. Analyst Commentary Recent Street research on GMR Solutions highlights a mix of optimism about the company’s position in U.S. emergency medical services and air operations, alongside a more cautious strand that focuses on execution risks, valuation, and the pace at which management can deliver on its plans.お知らせ • Jul 08GMR Solutions, Inc. Announces Board and Committee Appointments, Effective July 1, 2026GMR Solutions Inc. announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. Dr. Desai is a respected healthcare executive, with a career spanning medicine, public health and executive leadership across integrated healthcare systems, physician organizations and Fortune 100 healthcare companies. Most recently he served as President of Optum Integrated Care, where he helped advance clinical quality, patient outcomes and value-based care strategies. Before that, Dr. Desai was Chief Executive Officer of Optum Health at UnitedHealth Group, overseeing one of the country's largest care delivery organizations serving more than 20 million patients. His leadership experience includes senior roles at CVS Health, DaVita, USC Care, and McKinsey & Company. Dr. Desai will serve on the Board's Nominating, Corporate Governance and Compliance Committee. Ellen Zane is CEO Emeritus of Tufts Medical Center and Founding Chair of Tufts Medicine. Zane currently serves on the boards of Boston Scientific, Haemonetics Corporation and Synchrony Financial, among other organizations, and serves as Adjunct Assistant Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health. Zane will serve as Chair of the Board's Human Capital and Compensation Committee. The GMRS Board includes healthcare and investment leaders such as Timothy Wicks, former Chief Financial Officer of Optum and former Chief Executive Officer of OptumRx; Jan Stern Reed, former Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance Inc.; Johnny Kim, Managing Director on KKR's Health Care industry team; Max Lin, Partner and Head of KKR's Health Care industry team; and GMR Chief Executive Officer and Chairman, Nick Loporcaro. Together, these leaders bring experience that spans nearly every facet of the healthcare ecosystem—from care delivery and health system operations to governance, workforce leadership, finance and value-based care. Their combined expertise reflects GMR's vision for the future of emergency medical services—one in which EMS is increasingly recognized as an essential component of the broader healthcare system.新しいナラティブ • Jul 08Rural Health Expansion And Higher Acuity Volumes Will Reshape Long Term Earnings PowerCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air, supporting 5.5 million patient encounters each year in markets covering more than 60% of the U.S. population. What are the underlying business or industry changes driving this perspective?Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$15.46, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Healthcare industry in the US.新しいナラティブ • Jun 24Rural Health Focus And Surprise Billing Clarity Will Support Future Earnings PotentialCatalysts About GMR Solutions GMR Solutions provides emergency medical services through a national network of ground and air transport, supported by technology enabled care coordination platforms. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Jun 18GMR Solutions: The Post-IPO Discount Looks Too HarshSummary GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS’s scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics. Downside risks include reimbursement volatility and 3.5x net leverage, but deleveraging and execution could close the valuation gap versus peers. Read the full article on Seeking AlphaValuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$13.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Healthcare industry in the US.新しいナラティブ • Jun 09Regulatory And Payer Risks Will Pressure Emergency Coverage Yet Rural Program Upside Will EmergeCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air transport, handling millions of patient encounters each year in the U.S. What are the underlying business or industry changes driving this perspective? Coverage of communities representing over 60% of the U.S. population and 5.5 million annual patient encounters gives GMR broad exposure to emergency care demand.お知らせ • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.お知らせ • May 26GMR Solutions Inc. to Report Q1, 2026 Results on Jun 02, 2026GMR Solutions Inc. announced that they will report Q1, 2026 results on Jun 02, 2026ライブニュース • May 18GMR Solutions Gains Ratings Upgrades After IPO and Debt ReductionGMR Solutions and its subsidiary Global Medical Response received upgraded credit ratings from Moody's Ratings and S&P Global Ratings following the company's IPO. Moody's raised GMR's corporate family rating to B1 from B2, while S&P assigned a B+ issuer credit rating and upgraded Global Medical Response to B+ from B. The agencies cited a strengthened financial profile, improved leverage position, greater financial flexibility, and lower annualized financing costs as key drivers for the upgrades. Stronger credit ratings typically give a company more options when it comes to refinancing, extending maturities, or pursuing future funding on potentially more favorable terms. For you, the key thing to watch now is how GMR Solutions uses this improved financial footing, including any changes to its capital structure, interest expenses, or appetite for acquisitions and growth investments.お知らせ • May 14GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million.GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million. Security Name: Class A Common Stock Security Type: Common Stock Securities Offered: 31,914,893 Price\Range: $15 Discount Per Security: $0.75 Transaction Features: Reserved Share Offering; Sponsor Backed OfferingBoard Change • May 13No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO & Chairman of the Board Nick Loporcaro was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.業績と収益の成長予測NYSE:GMRS - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20286,741470705913612/31/20276,371411599696712/31/20266,03216148951976/30/20265,878-76355640N/A3/31/20265,83080310581N/A12/31/20255,74036383641N/A12/31/20245,976-70-22246N/A12/31/20235,395-20387258N/Aアナリストによる今後の成長予測収入対貯蓄率: GMRSは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 3.7% ) よりも高い成長率であると考えられます。収益対市場: GMRS今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: GMRS今後 3 年以内に収益を上げることが予想されます。収益対市場: GMRSの収益 ( 5.5% ) US市場 ( 13% ) よりも低い成長が予測されています。高い収益成長: GMRSの収益 ( 5.5% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: GMRSの 自己資本利益率 は、3年後には高くなると予測されています ( 36.5 %)成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/08/18 23:22終値2026/08/18 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋GMR Solutions Inc. 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Andrew MokBarclaysJoanna Sylvia GajukBofA Global ResearchDaniel GrosslightCitigroup Inc5 その他のアナリストを表示
お知らせ • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.
お知らせ • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.
お知らせ • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.
Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ellen Zane was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 24GMR Solutions Inc. to Report Q2, 2026 Results on Aug 13, 2026GMR Solutions Inc. announced that they will report Q2, 2026 results Pre-Market on Aug 13, 2026
お知らせ • Jul 11GMR Solutions Inc.Appoints Jan Stern Reed to Chair of the Board's Nominating, Corporate Governance and Compliance Committee and A Member of the Board's Audit CommitteeGMR Solutions Inc. As of July 1, 2026, Ms. Jan Stern Reed 's preliminary committee assignments have been finalized. Ms. Reed is serving as the Chair of the Board's Nominating, Corporate Governance and Compliance Committee and a member of the Board's Audit Committee.
ナラティブ更新 • Jul 10GMRS: Higher Discount Rate Will Pressure Confidence In Air Operations DeliveryThe analyst price target for GMR Solutions has been reduced from $15 to $14, as analysts factor in a higher discount rate while still highlighting the company’s scale in U.S. emergency medical services and the potential benefits from higher margin air operations and contract stability. Analyst Commentary Recent Street research on GMR Solutions highlights a mix of optimism about the company’s position in U.S. emergency medical services and air operations, alongside a more cautious strand that focuses on execution risks, valuation, and the pace at which management can deliver on its plans.
お知らせ • Jul 08GMR Solutions, Inc. Announces Board and Committee Appointments, Effective July 1, 2026GMR Solutions Inc. announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. Dr. Desai is a respected healthcare executive, with a career spanning medicine, public health and executive leadership across integrated healthcare systems, physician organizations and Fortune 100 healthcare companies. Most recently he served as President of Optum Integrated Care, where he helped advance clinical quality, patient outcomes and value-based care strategies. Before that, Dr. Desai was Chief Executive Officer of Optum Health at UnitedHealth Group, overseeing one of the country's largest care delivery organizations serving more than 20 million patients. His leadership experience includes senior roles at CVS Health, DaVita, USC Care, and McKinsey & Company. Dr. Desai will serve on the Board's Nominating, Corporate Governance and Compliance Committee. Ellen Zane is CEO Emeritus of Tufts Medical Center and Founding Chair of Tufts Medicine. Zane currently serves on the boards of Boston Scientific, Haemonetics Corporation and Synchrony Financial, among other organizations, and serves as Adjunct Assistant Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health. Zane will serve as Chair of the Board's Human Capital and Compensation Committee. The GMRS Board includes healthcare and investment leaders such as Timothy Wicks, former Chief Financial Officer of Optum and former Chief Executive Officer of OptumRx; Jan Stern Reed, former Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance Inc.; Johnny Kim, Managing Director on KKR's Health Care industry team; Max Lin, Partner and Head of KKR's Health Care industry team; and GMR Chief Executive Officer and Chairman, Nick Loporcaro. Together, these leaders bring experience that spans nearly every facet of the healthcare ecosystem—from care delivery and health system operations to governance, workforce leadership, finance and value-based care. Their combined expertise reflects GMR's vision for the future of emergency medical services—one in which EMS is increasingly recognized as an essential component of the broader healthcare system.
新しいナラティブ • Jul 08Rural Health Expansion And Higher Acuity Volumes Will Reshape Long Term Earnings PowerCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air, supporting 5.5 million patient encounters each year in markets covering more than 60% of the U.S. population. What are the underlying business or industry changes driving this perspective?
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$15.46, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Healthcare industry in the US.
新しいナラティブ • Jun 24Rural Health Focus And Surprise Billing Clarity Will Support Future Earnings PotentialCatalysts About GMR Solutions GMR Solutions provides emergency medical services through a national network of ground and air transport, supported by technology enabled care coordination platforms. What are the underlying business or industry changes driving this perspective?
Seeking Alpha • Jun 18GMR Solutions: The Post-IPO Discount Looks Too HarshSummary GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS’s scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics. Downside risks include reimbursement volatility and 3.5x net leverage, but deleveraging and execution could close the valuation gap versus peers. Read the full article on Seeking Alpha
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$13.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Healthcare industry in the US.
新しいナラティブ • Jun 09Regulatory And Payer Risks Will Pressure Emergency Coverage Yet Rural Program Upside Will EmergeCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air transport, handling millions of patient encounters each year in the U.S. What are the underlying business or industry changes driving this perspective? Coverage of communities representing over 60% of the U.S. population and 5.5 million annual patient encounters gives GMR broad exposure to emergency care demand.
お知らせ • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.
お知らせ • May 26GMR Solutions Inc. to Report Q1, 2026 Results on Jun 02, 2026GMR Solutions Inc. announced that they will report Q1, 2026 results on Jun 02, 2026
ライブニュース • May 18GMR Solutions Gains Ratings Upgrades After IPO and Debt ReductionGMR Solutions and its subsidiary Global Medical Response received upgraded credit ratings from Moody's Ratings and S&P Global Ratings following the company's IPO. Moody's raised GMR's corporate family rating to B1 from B2, while S&P assigned a B+ issuer credit rating and upgraded Global Medical Response to B+ from B. The agencies cited a strengthened financial profile, improved leverage position, greater financial flexibility, and lower annualized financing costs as key drivers for the upgrades. Stronger credit ratings typically give a company more options when it comes to refinancing, extending maturities, or pursuing future funding on potentially more favorable terms. For you, the key thing to watch now is how GMR Solutions uses this improved financial footing, including any changes to its capital structure, interest expenses, or appetite for acquisitions and growth investments.
お知らせ • May 14GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million.GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million. Security Name: Class A Common Stock Security Type: Common Stock Securities Offered: 31,914,893 Price\Range: $15 Discount Per Security: $0.75 Transaction Features: Reserved Share Offering; Sponsor Backed Offering
Board Change • May 13No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO & Chairman of the Board Nick Loporcaro was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.